Related Experiment Video
Updated: Jul 6, 2026
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Rapamycin impairs beta-cell proliferation in vivo
E Zahr1, R D Molano, A Pileggi
1Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, USA.
Transplantation Proceedings
|April 1, 2008
Summary
Pregnancy increases beta-cell proliferation, but Rapamycin treatment reduces this effect in mice. This suggests Rapamycin may impair beta-cell renewal in transplant patients.
Area of Science:
- Endocrinology
- Cell Biology
- Immunology
Background:
- Pregnancy stimulates significant beta-cell proliferation, serving as a model for islet cell expansion.
- Rapamycin is crucial for preventing graft rejection in transplant recipients, including islet transplantation.
Purpose of the Study:
- To investigate the impact of Rapamycin on beta-cell proliferation during pregnancy in a murine model.
- To assess the effects of Rapamycin on islet function in vivo and in vitro.
Main Methods:
- Utilized a murine pregnancy model to study islet cell dynamics.
- Administered Rapamycin to pregnant mice and analyzed beta-cell proliferation, islet yield, and insulin content.
- Evaluated islet function and molecular signaling pathways (p70s6k, ERK1/2 phosphorylation).
Main Results:
- Pregnancy significantly increased beta-cell proliferation, islet yield, and insulin content compared to non-pregnant controls.
- Rapamycin treatment markedly reduced beta-cell proliferation in pregnant mice.
- Rapamycin showed minimal impact on overall islet function but altered key signaling molecules (decreased p70s6k, increased ERK1/2 phosphorylation).
Conclusions:
- Beta-cell replication is diminished by Rapamycin treatment in vivo.
- These findings suggest Rapamycin may hinder beta-cell regeneration in patients undergoing transplantation.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...